Erythromycin is a broad-spectrum macrolide antibiotic derived from�Saccharomyces erythraeus. As an active pharmaceutical ingredient (API), it inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Primarily effective against Gram-positive bacteria and some atypical pathogens, it is a key therapeutic agent for respiratory tract infections, skin conditions, and sexually transmitted diseases like chlamydia. The API is typically formulated into oral tablets, suspensions, topical solutions, and intravenous preparations. Its production involves complex fermentation and purification processes. As a classic antibiotic, erythromycin remains essential in clinical practice, especially for patients with penicillin allergies.